Shanghai Haohai Biological Technology Co., Ltd. (FRA:5HB)

Germany · Delayed Price · Currency is EUR

1.760

0.00 (0.00%)

At close: Aug 26, 2026

-44.30% (1Y)

Market Cap	786.95M -44.7%
Revenue (ttm)	300.60M -9.4%
Net Income	19.66M -61.5%
EPS	0.09 -61.2%
Shares Out	n/a
PE Ratio	40.03
Forward PE	n/a
Dividend	0.11 (6.13%)
Ex-Dividend Date	Sep 4, 2026

Volume	n/a
Open	1.750
Previous Close	1.760
Day's Range	1.750 - 1.760
52-Week Range	1.660 - 3.180
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About FRA:5HB

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ... [Read more]

Industry Pharmaceutical Preparations

Founded 2007

Employees 2,110

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 5HB

Financial Performance

In 2025, FRA:5HB's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.

Financial numbers in CNY Financial Statements